Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$126.42
-1.63%
Mkt Cap $20.18B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $1.12B | $1.16B | +3.60% | $1.24 | $1.35 | +8.87% | — | — |
| Q4 2025 Oct 30, 2025 | $1.07B | $1.08B | +1.65% | $1.17 | $1.34 | +14.53% | — | — |
| Q3 2025 Jul 31, 2025 | $1.06B | $1.06B | -0.56% | $1.02 | $1.19 | +16.67% | — | — |
| Q2 2025 May 8, 2025 | $1.03B | $1.04B | +1.52% | $0.94 | $0.97 | +3.19% | — | — |
| Q1 2025 Feb 6, 2025 | $1.07B | $1.10B | +3.00% | $0.92 | $0.86 | -6.52% | — | — |
| Q4 2024 Nov 4, 2024 | $1.08B | $1.08B | +0.00% | $0.88 | $1.14 | +29.69% | — | — |
| Q3 2024 Aug 6, 2024 | $1.09B | $1.11B | +1.73% | $0.11 | $0.36 | +228.47% | — | — |
| Q2 2024 May 2, 2024 | $1.05B | $1.08B | +2.44% | $0.04 | $0.09 | +106.42% | — | — |
| Q1 2024 Feb 8, 2024 | $1.09B | $1.12B | +3.13% | $0.02 | $0.14 | +686.08% | — | — |
| Q4 2023 Nov 9, 2023 | $1.13B | $1.12B | -1.03% | $0.13 | $0.33 | +153.85% | — | — |
| Q3 2023 Aug 9, 2023 | $1.16B | $1.18B | +1.08% | $0.02 | $0.32 | +1636.30% | — | — |
| Q2 2023 Apr 25, 2023 | $1.17B | $1.09B | -6.82% | $0.03 | $0.08 | +215.83% | — | — |
| Q1 2023 Feb 7, 2023 | $1.07B | $1.08B | +1.04% | $0.19 | $0.14 | -26.32% | — | — |
| Q4 2022 Nov 3, 2022 | $1.11B | $1.11B | +0.36% | $0.29 | $0.34 | +17.24% | — | — |
| Q3 2022 Aug 11, 2022 | $1.22B | $1.16B | -4.90% | $0.63 | $0.57 | -9.52% | — | — |
| Q2 2022 May 5, 2022 | $1.22B | $1.22B | +0.32% | $0.87 | $1.07 | +22.99% | — | — |
| Q1 2022 Feb 10, 2022 | $1.13B | $1.20B | +6.36% | $0.49 | $0.75 | +53.06% | — | — |
| Q4 2021 Nov 4, 2021 | $1.04B | $1.11B | +6.24% | $1.24 | $1.45 | +16.94% | — | — |
| Q3 2021 Aug 5, 2021 | $1.02B | $1.13B | +10.64% | $1.36 | $1.87 | +37.50% | — | — |
| Q2 2021 Apr 27, 2021 | $925.20M | $1.09B | +18.14% | $1.36 | $1.89 | +38.97% | — | — |